Literature DB >> 16549843

Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.

Michele D Mignogna1, Stefano Fedele, Lucio Lo Russo, Roberto Ciccarelli, Lorenzo Lo Muzio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16549843     DOI： 10.1200/JCO.2005.01.7756

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

Authors:  Anita P Price; Sara J Abramson; Sinchun Hwang; Alexander Chou; Roger Bartolotta; Paul Meyers; Douglas S Katz
Journal:  Pediatr Radiol       Date:  2010-10-30

2.  Osteonecrosis of maxilla secondary to bisphosphonate therapy: a case report.

Authors:  Trupti Kolur; Sanjiv C Nair; Balasubramanya Kumar
Journal:  J Maxillofac Oral Surg       Date:  2011-12-21

3.  FDG-PET may predict the effectiveness of hyperbaric oxygen therapy in a patient with bisphosphonate-related osteonecrosis of the jaw: report of a case.

Authors:  Chowdhury Nusrat Fatema; Jun Sato; Yutaka Yamazaki; Hironobu Hata; Naoya Hattori; Tohru Shiga; Nagara Tamaki; Yoshimasa Kitagawa
Journal:  Odontology       Date:  2013-08-02       Impact factor: 2.634

4.  Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.

Authors:  Rebecca Anne Miksad; Kuan-Chi Lai; Thomas Benton Dodson; Sook-Bin Woo; Nathaniel Simon Treister; Omosalewa Akinyemi; Marian Bihrle; Guy Maytal; Meredith August; G Scott Gazelle; J Shannon Swan
Journal:  Oncologist       Date:  2011-01-06

5.  Stage-related treatment concept of medication-related osteonecrosis of the jaw-a case series.

Authors:  Petra Rugani; Stephan Acham; Barbara Kirnbauer; Astrid Truschnegg; Barbara Obermayer-Pietsch; Norbert Jakse
Journal:  Clin Oral Investig       Date:  2014-12-17       Impact factor: 3.573

6.  Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy.

Authors:  Tatjana I Jung; Falk Hoffmann; Gerd Glaeske; Dieter Felsenberg
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-22       Impact factor: 4.553

Review 7.  Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.

Authors:  Franco Capsoni; Matteo Longhi; Roberto Weinstein
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.